Recombinant Human Anti-CD64 x Human Anti-malaria antigen Bispecific Antibody (Miniantibody) (MNAB-H303)

Recombinant Anti-CD64 x Anti-malaria antigen Bispecific Antibody (Miniantibody) is a fusion protein of two scFv fragments combined with distinct specificity. One scFv of an anti-CD64 antibody variable domain is linked to another scFv of an anti-malaria antigen antibody variable domain by a flexible hinge region. This BsAb format has the decreased size and better penetration than conventional IgGs in the clinical diagnostics and potentially therapy. This BsAb can retarget NK cells to genus plasmodium. It is designed for the research of Malaria therapy.

Datasheet INQUIRY

Specifications

Targets

CD64 & malaria antigen

Type

scFv-based Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Malaria

Targets

Target 1

CD64

Gene ID

2209

UniProt ID

P12314

Alternative Names

FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI

Target 2

malaria antigen

Alternative Names

malaria antigen; parasitic protozoans

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Related products of "CD64 & malaria antigen"

See other bsAb targets related to "CD64"

See other bsAb targets related to "malaria antigen"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CD64 x Human Anti-malaria antigen Bispecific Antibody (Miniantibody) (MNAB-H303). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-CD64 x Human Anti-malaria antigen Bispecific Antibody (Miniantibody) (CAT#: MNAB-H303)

Specifications

Targets

Customer Reviews and Q&As